Masimo (NASDAQ:MASI) is scheduled to post its quarterly earnings results after the market closes on Tuesday, February 27th. Analysts expect Masimo to post earnings of $0.61 per share for the quarter.
Shares of Masimo (NASDAQ:MASI) opened at $86.68 on Tuesday. The company has a market cap of $4,480.00, a P/E ratio of 13.74, a PEG ratio of 3.29 and a beta of 0.85. Masimo has a 52-week low of $80.69 and a 52-week high of $104.71.
In other news, EVP Yongsam Lee sold 18,198 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $88.85, for a total transaction of $1,616,892.30. Following the completion of the sale, the executive vice president now owns 70,800 shares of the company’s stock, valued at approximately $6,290,580. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Sanford Fitch sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 25th. The stock was sold at an average price of $90.00, for a total transaction of $180,000.00. Following the sale, the director now directly owns 70,249 shares of the company’s stock, valued at approximately $6,322,410. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 48,098 shares of company stock valued at $4,315,261. Insiders own 13.10% of the company’s stock.
Several analysts have recently commented on the stock. Zacks Investment Research downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 7th. BidaskClub downgraded shares of Masimo from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $108.00 price objective on shares of Masimo in a research report on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. Masimo presently has an average rating of “Hold” and an average target price of $104.60.
Masimo Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.